175 related articles for article (PubMed ID: 34130695)
1. Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy.
Fei W; Zhao Y; Wu X; Sun D; Yao Y; Wang F; Zhang M; Li C; Qin J; Zheng C
J Nanobiotechnology; 2021 Jun; 19(1):184. PubMed ID: 34130695
[TBL] [Abstract][Full Text] [Related]
2. Equilibrative Nucleoside Transporter 1 (ENT1,
Cerveny L; Ptackova Z; Ceckova M; Karahoda R; Karbanova S; Jiraskova L; Greenwood SL; Glazier JD; Staud F
Drug Metab Dispos; 2018 Nov; 46(11):1817-1826. PubMed ID: 30097436
[TBL] [Abstract][Full Text] [Related]
3. Dual-responsive, Methotrexate-loaded, Ascorbic acid-derived Micelles Exert Anti-tumor and Anti-metastatic Effects by Inhibiting NF-κB Signaling in an Orthotopic Mouse Model of Human Choriocarcinoma.
Wei L; Wang C; Chen X; Yang B; Shi K; Benington LR; Lim LY; Shi S; Mo J
Theranostics; 2019; 9(15):4354-4374. PubMed ID: 31285766
[TBL] [Abstract][Full Text] [Related]
4. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake.
Nishimura T; Sano Y; Takahashi Y; Noguchi S; Uchida Y; Takagi A; Tanaka T; Katakura S; Nakashima E; Tachikawa M; Maruyama T; Terasaki T; Tomi M
J Pharm Sci; 2019 Dec; 108(12):3917-3922. PubMed ID: 31520644
[TBL] [Abstract][Full Text] [Related]
5. Characterization of mENT1Delta11, a novel alternative splice variant of the mouse equilibrative nucleoside transporter 1.
Robillard KR; Bone DB; Park JS; Hammond JR
Mol Pharmacol; 2008 Jul; 74(1):264-73. PubMed ID: 18413666
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
[TBL] [Abstract][Full Text] [Related]
7. Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice.
Anderson JT; Hu S; Fu Q; Baker SD; Sparreboom A
Pharmacol Res Perspect; 2019 Dec; 7(6):e00534. PubMed ID: 31832201
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside/nucleobase transport and metabolism by microvascular endothelial cells isolated from ENT1-/- mice.
Bone DB; Choi DS; Coe IR; Hammond JR
Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H847-56. PubMed ID: 20543083
[TBL] [Abstract][Full Text] [Related]
9. FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.
Català A; Pastor-Anglada M; Caviedes-Cárdenas L; Malatesta R; Rives S; Vega-García N; Camós M; Fernández-Calotti P
Oncotarget; 2016 Aug; 7(31):49786-49799. PubMed ID: 27391351
[TBL] [Abstract][Full Text] [Related]
10. Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.
Cai J; Peng T; Wang J; Zhang J; Hu H; Tang D; Chu C; Yang T; Liu H
Cell Physiol Biochem; 2016; 39(4):1421-32. PubMed ID: 27606814
[TBL] [Abstract][Full Text] [Related]
11. Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.
Moss AM; Endres CJ; Ruiz-Garcia A; Choi DS; Unadkat JD
Mol Pharm; 2012 Sep; 9(9):2442-9. PubMed ID: 22812541
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
13. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
[TBL] [Abstract][Full Text] [Related]
14. Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.
Krys D; Hamann I; Wuest M; Wuest F
FASEB J; 2019 Dec; 33(12):13837-13851. PubMed ID: 31601121
[TBL] [Abstract][Full Text] [Related]
15. AKR1C3 overexpression mediates methotrexate resistance in choriocarcinoma cells.
Zhao J; Xiang Y; Xiao C; Guo P; Wang D; Liu Y; Shen Y
Int J Med Sci; 2014; 11(11):1089-97. PubMed ID: 25170291
[TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract][Full Text] [Related]
17. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
[TBL] [Abstract][Full Text] [Related]
18. Transporter occluded-state conformation-induced endocytosis: Amino acid transporter ATB
Luo Q; Gong P; Sun M; Kou L; Ganapathy V; Jing Y; He Z; Sun J
J Control Release; 2016 Dec; 243():370-380. PubMed ID: 27810556
[TBL] [Abstract][Full Text] [Related]
19. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
20. Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents.
Chen Y; Qian H; Wang H; Zhang X; Fu M; Liang X; Ma Y; Zhan Q; Lin C; Xiang Y
Gynecol Oncol; 2007 Dec; 107(3):505-12. PubMed ID: 17884151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
